So glad someone picked up on it - they mention it twice - the studies main endpoint was to see if it was safe!
second - to if the tech works - which is programming the t cells to to do the work - which clearly they they did and with a bit of tweaking can (possibly) achieve the result that satisfies the creation of a vaccine be that 92% and above who knows?
i think this has bee missed, as your eyes are drawn into the high beams of the result 58% and 80%
makes FDA approval a given (logical using bodies own cells) , now they just need to tweak the program
i am not in this for the Vax as most of you know but this to me is extremely positive - assessing further details in 2017
Ann: HSV-2 Interim Results Announcement-AHZ.AX, page-92
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.90 |
Change
0.120(1.23%) |
Mkt cap ! $209.0M | |||
| Open | High | Low | Value | Volume |
| $9.85 | $10.78 | $9.60 | $351.4K | 35.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 288 | $9.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.92 | 303 | 3 |
View Market Depth
| Last trade - 14.23pm 19/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |